Related Experiment Videos
Role of IgA in IgA nephropathy
1Department of Pediatrics, University of Alabama, Birmingham.
The Journal of Pediatrics
|May 1, 1990
Summary
IgA nephropathy (Berger disease) involves IgA deposition in the kidneys. However, research suggests IgG and complement activation are crucial for kidney injury, not just IgA. Further studies should focus on these factors.
Area of Science:
- Nephrology
- Immunology
- Renal Pathology
Background:
- IgA nephropathy (Berger disease) is characterized by IgA deposition in the renal mesangium.
- Evidence suggests an up-regulated systemic IgA immune response in patients.
- Increased IgA production alone may not fully explain the disease's pathogenesis.
Purpose of the Study:
- To investigate the roles of IgG and complement in IgA nephropathy pathogenesis.
- To clarify the interaction between IgA, IgG, and complement in immune complexes.
- To determine factors contributing to renal injury beyond IgA deposition.
Main Methods:
- Analysis of circulating immune complexes from IgA nephropathy patients.
- In vitro studies using model immune aggregates of IgA and IgG.
- Examination of murine models of IgA nephropathy.
Main Results:
- Circulating immune complexes contain both IgA and IgG.
- IgG, not IgA, mediates complement activation and fixation in immune aggregates.
- IgA can inhibit complement activation and immune complex clearance.
Conclusions:
- IgG and local complement activation are essential for mesangial cell proliferation and renal injury in IgA nephropathy.
- The role of IgA may involve inhibiting immune complex clearance.
- Future research should emphasize the contributions of IgG and complement to disease pathogenesis.